» Articles » PMID: 22875822

Remote Ischaemic Preconditioning in Coronary Artery Bypass Surgery: a Meta-analysis

Abstract

Aim: Randomised trials exploring remote ischaemic preconditioning (RIPC) in patients undergoing coronary artery bypass graft (CABG) surgery have yielded conflicting data regarding potential cardiovascular and renal protection, and are individually flawed by small sample size.

Methods: Three investigators independently searched the MEDLINE, EMBASE and Cochrane databases to identify randomised trials testing RIPC in patients undergoing CABG.

Results: Nine studies with 704 patients were included. Standardised mean difference of troponin I and T release showed a significant decrease (-0.36 (95% CI -0.62 to -0.09)). This difference held true after excluding the trials with cross-clamp fibrillation, the study with off-pump CABG and studies using a flurane as anaesthetic agent (-0.41 (95% CI -0.69 to -0.12), -0.38 (95% CI -0.70 to -0.07) and -0.37 (95% CI -0.63 to -0.12), respectively). A similar trend was also obtained for patients with multivessel disease (-0.41 (95% CI -0.73 to -0.08)). The trials evaluating postoperative creatinine reported a non-significant reduction (0.02 (95% CI -0.09 to 0.13)). Moreover, the length of in-hospital stay was not influenced by the kind of treatment (weighted mean difference 0.27 (95% CI -0.24 to 0.79)).

Conclusion: RIPC reduced the release of troponin in patients undergoing CABG. Larger randomised trials are needed to clarify the presence of a causal relationship between RIPC-induced troponin release and clinical adverse events.

Citing Articles

Effects of Remote Ischemic Preconditioning on Decreasing Troponin Release in Patients Not Taking Sulfonylureas After Cardiac Surgery - A Meta-Analysis.

Wang X, Xiao S, Hu Y, Guo M, Liu A, Huan C Braz J Cardiovasc Surg. 2023; 38(2):280-299.

PMID: 36592075 PMC: 10069259. DOI: 10.21470/1678-9741-2022-0160.


Dose-dependent effects of perfluorocarbon-based blood substitute on cardiac function in myocardial ischemia-reperfusion injury.

Jakovljevic V, Vorobyev S, Bolevich S, Morozova E, Bolevich S, Saltykov A Mol Cell Biochem. 2022; 477(12):2773-2786.

PMID: 35643877 DOI: 10.1007/s11010-022-04479-0.


FOXO3a-mediated long non-coding RNA LINC00261 resists cardiomyocyte hypoxia/reoxygenation injury via targeting miR23b-3p/NRF2 axis.

Zhang R, Li Y, Liu X, Qin S, Guo B, Chang L J Cell Mol Med. 2020; 24(15):8368-8378.

PMID: 32558131 PMC: 7412708. DOI: 10.1111/jcmm.15292.


Primary graft dysfunction after heart transplantation: a thorn amongst the roses.

Avtaar Singh S, Dalzell J, Berry C, Al-Attar N Heart Fail Rev. 2019; 24(5):805-820.

PMID: 31020451 PMC: 6697758. DOI: 10.1007/s10741-019-09794-1.


Remote ischemic preconditioning for cardioprotection in elective inpatient abdominal surgery - a randomized controlled trial.

Antonowicz S, Cavallaro D, Jacques N, Brown A, Wiggins T, Haddow J BMC Anesthesiol. 2018; 18(1):76.

PMID: 29945555 PMC: 6020340. DOI: 10.1186/s12871-018-0524-6.